CME Group, Inc. (CME) Tops Q2 EPS Views; Revs Strong
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CME Hot Sheet
Price: $307.17 +1.02%
Financial Fact:
Total Non-Operating: 23.5M
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Total Non-Operating: 23.5M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
CME Group, Inc. (NASDAQ: CME) reported Q2 EPS of $4.38, $0.21 better than the analyst estimate of $4.17. Revenue for the quarter came in at $838 million versus the consensus estimate of $821.33 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CME Group posts record October ADV of 30M contracts, up 15%
- SharkNinja (SN) Tops Q3 EPS by 74c; Offers Guidance
- Harmony Biosciences (HRMY) Misses Q3 EPS by 30c; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
